Es gab 50 kürzliche Insider-Transaktionen für Chimerix, Inc. (CMRX), darunter 20 Käufe und 27 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $946.15K und die gesamten Insider-Verkäufe auf $8.08M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Demski Martha J, Kozin Marc D, Middleton Fred A. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — CMRX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-04-21 |
Demski Martha J |
Director |
Aktienrückgabe |
60,000 |
$0.89 |
$53.4K |
- |
| 2025-04-21 |
Kozin Marc D |
Director |
Aktienrückgabe |
60,000 |
$0.89 |
$53.4K |
- |
| 2025-04-21 |
Middleton Fred A |
Director |
Aktienrückgabe |
60,000 |
$0.89 |
$53.4K |
- |
| 2025-04-21 |
Alrutz Michael Albert |
SVP and General Counsel |
Aktienrückgabe |
250,000 |
$3.66 |
$915K |
- |
| 2025-04-21 |
Sherman Michael A. |
Chief Executive Officer |
Aktienrückgabe |
60,000 |
$0.89 |
$53.4K |
- |
| 2025-04-21 |
Multani Pratik S |
Director |
Aktienrückgabe |
60,000 |
$0.89 |
$53.4K |
- |
| 2025-04-21 |
Andriole Michael T. |
President and CEO |
Aktienrückgabe |
900,000 |
$3.66 |
$3.29M |
- |
| 2025-04-21 |
Riga Thomas J |
COO and Cco |
Aktienrückgabe |
325,000 |
$3.66 |
$1.19M |
- |
| 2025-04-21 |
Meyer Robert J. |
Director |
Aktienrückgabe |
60,000 |
$0.89 |
$53.4K |
- |
| 2025-04-21 |
Jakeman David |
VP of Finance and Accounting |
Aktienrückgabe |
65,000 |
$3.66 |
$237.9K |
- |
| 2025-04-21 |
Decker Lisa Lynn |
Director |
Aktienrückgabe |
60,000 |
$0.89 |
$53.4K |
- |
| 2025-04-21 |
Melemed Allen S. |
Chief Medical Officer |
Aktienrückgabe |
275,000 |
$3.66 |
$1.01M |
- |
| 2025-04-21 |
Vakiener Victoria |
Director |
Aktienrückgabe |
60,000 |
$0.89 |
$53.4K |
- |
| 2025-04-21 |
Laspaluto Michelle |
Chief Financial Officer |
Aktienrückgabe |
250,000 |
$3.66 |
$915K |
- |
| 2025-02-13 |
Alrutz Michael Albert |
SVP and General Counsel |
Informierter Verkauf |
1,600 |
$4.52 |
$7.23K |
213,596 |
| 2025-02-13 |
Andriole Michael T. |
President and CEO |
Informierter Verkauf |
7,370 |
$4.52 |
$33.28K |
609,603 |
| 2025-02-13 |
Jakeman David |
VP of Finance and Accounting |
Informierter Verkauf |
300 |
$4.53 |
$1.36K |
148,987 |
| 2025-02-13 |
Melemed Allen S. |
Chief Medical Officer |
Informierter Verkauf |
3,065 |
$4.50 |
$13.8K |
152,875 |
| 2025-02-13 |
Laspaluto Michelle |
Chief Financial Officer |
Informierter Verkauf |
2,260 |
$4.51 |
$10.2K |
172,977 |
| 2025-01-30 |
Andriole Michael T. |
President and CEO |
Informierter Verkauf |
2,350 |
$4.10 |
$9.64K |
616,973 |
| 2025-01-30 |
Jakeman David |
VP of Finance and Accounting |
Informierter Verkauf |
2,800 |
$4.10 |
$11.47K |
149,287 |
| 2025-01-30 |
Laspaluto Michelle |
Chief Financial Officer |
Informierter Verkauf |
1,015 |
$4.11 |
$4.17K |
175,237 |
| 2025-01-07 |
Alrutz Michael Albert |
SVP and General Counsel |
RSU-Zuteilung |
41,667 |
- |
- |
215,196 |
| 2025-01-07 |
Andriole Michael T. |
President and CEO |
RSU-Zuteilung |
150,000 |
- |
- |
619,323 |
| 2025-01-07 |
Riga Thomas J |
COO and Cco |
RSU-Zuteilung |
54,275 |
- |
- |
57,501 |
| 2025-01-07 |
Jakeman David |
VP of Finance and Accounting |
RSU-Zuteilung |
65,000 |
$3.66 |
$237.9K |
65,000 |
| 2025-01-07 |
Melemed Allen S. |
Chief Medical Officer |
RSU-Zuteilung |
45,925 |
- |
- |
155,940 |
| 2025-01-07 |
Laspaluto Michelle |
Chief Financial Officer |
RSU-Zuteilung |
41,667 |
- |
- |
176,252 |
| 2024-10-28 |
Middleton Fred A |
Director |
Schenkung (gegeben) |
60,000 |
- |
- |
40,000 |
| 2024-08-08 |
Andriole Michael T. |
President and CEO |
Informierter Verkauf |
1,285 |
$0.83 |
$1.06K |
462,453 |
| 2024-06-20 |
Demski Martha J |
Director |
RSU-Zuteilung |
60,000 |
$0.89 |
$53.4K |
60,000 |
| 2024-06-20 |
Kozin Marc D |
Director |
RSU-Zuteilung |
60,000 |
$0.89 |
$53.4K |
60,000 |
| 2024-06-20 |
Middleton Fred A |
Director |
RSU-Zuteilung |
60,000 |
$0.89 |
$53.4K |
60,000 |
| 2024-06-20 |
Sherman Michael A. |
Chief Executive Officer |
RSU-Zuteilung |
60,000 |
$0.89 |
$53.4K |
60,000 |
| 2024-06-20 |
Multani Pratik S |
Director |
RSU-Zuteilung |
60,000 |
$0.89 |
$53.4K |
60,000 |
| 2024-06-20 |
Meyer Robert J. |
Director |
RSU-Zuteilung |
60,000 |
$0.89 |
$53.4K |
60,000 |
| 2024-06-20 |
Decker Lisa Lynn |
Director |
RSU-Zuteilung |
60,000 |
$0.89 |
$53.4K |
60,000 |
| 2024-06-20 |
Vakiener Victoria |
Director |
RSU-Zuteilung |
60,000 |
$0.89 |
$53.4K |
60,000 |
| 2024-03-20 |
Kozin Marc D |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-03-20 |
Kozin Marc D |
Director |
RSU-Zuteilung |
100,000 |
$0.99 |
$99K |
100,000 |
| 2024-02-14 |
Andriole Michael T. |
President and CEO |
Informierter Verkauf |
1,744 |
$1.04 |
$1.81K |
447,021 |
| 2024-02-14 |
Jakeman David |
VP of Finance and Accounting |
Informierter Verkauf |
2,660 |
$1.04 |
$2.78K |
141,232 |
| 2024-02-14 |
Laspaluto Michelle |
Chief Financial Officer |
Informierter Verkauf |
1,940 |
$1.04 |
$2.02K |
110,999 |
| 2024-02-01 |
Alrutz Michael Albert |
SVP and General Counsel |
RSU-Zuteilung |
131,250 |
$0.93 |
$122.06K |
131,250 |
| 2024-02-01 |
Andriole Michael T. |
President and CEO |
RSU-Zuteilung |
83,750 |
- |
- |
448,765 |
| 2024-02-01 |
Jakeman David |
VP of Finance and Accounting |
RSU-Zuteilung |
64,500 |
$0.93 |
$59.99K |
64,500 |
| 2024-02-01 |
Melemed Allen S. |
Chief Medical Officer |
RSU-Zuteilung |
28,125 |
- |
- |
86,430 |
| 2024-02-01 |
Laspaluto Michelle |
Chief Financial Officer |
RSU-Zuteilung |
25,000 |
- |
- |
112,939 |
| 2023-12-29 |
Andriole Michael T. |
President and CEO |
Schenkung (gegeben) |
17,000 |
- |
- |
365,015 |
| 2023-12-28 |
Decker Lisa Lynn |
Director |
Veräußerung |
- |
- |
- |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
